10-Q: Henry Schein Reports Q1 2024 Results, Impacted by Cyber Incident

Henry Schein's first quarter results for 2024 were impacted by a cyber incident, though the company saw growth in technology and value-added services.

Summary

• Henry Schein's net sales for the first quarter of 2024 reached $3.172 billion, a 3.7% increase compared to $3.060 billion in the same period last year.
• The company's health care distribution segment saw a 3% increase in sales, while technology and value-added services experienced a 13.8% growth.
• The cyber incident in October 2023 continued to impact sales, particularly to episodic customers, and resulted in $5 million in direct expenses during the quarter.
• Net income attributable to Henry Schein was $93 million, down from $121 million in the prior year period.
• The company's effective tax rate was 25.6% for the quarter, compared to 23.8% in the same period last year.
• The company repurchased approximately $4.8 billion of common stock (91,393,533 shares) under these initiatives, with $190 million available for future common stock share repurchases.

Sentiment

Score: 5

Explanation: The document presents mixed results. While there is growth in some areas, the negative impact of the cyber incident and the decrease in net income temper the overall sentiment. The ongoing legal proceedings and restructuring efforts also add to the uncertainty.

Positives

• The technology and value-added services segment showed strong growth, indicating a positive trend in that area.
• The company continues to invest in acquisitions, which are expected to drive future growth.
• The company has a $60 million cyber insurance policy, which may help offset some of the costs associated with the cyber incident.
• The company has a strong brand identity due to its more than 91 years of experience distributing health care products.

Negatives

• The cyber incident had a negative impact on sales, particularly to episodic customers.
• Net income attributable to Henry Schein decreased from $121 million to $93 million year-over-year.
• The company incurred $5 million in direct expenses related to the cyber incident.
• The company's restructuring plan has been extended through the end of 2024, indicating ongoing challenges.

Risks

• The company is still experiencing residual impacts from the cyber incident, which could continue to affect sales.
• The company is involved in multiple opioid-related lawsuits, which could result in significant liabilities.
• The company is subject to extensive governmental laws and regulations, which could impact its financial performance.
• The company is exposed to risks associated with global operations, including geopolitical wars and fluctuations in currency exchange rates.
• The company is subject to risks associated with disease outbreaks, epidemics, pandemics (such as the COVID-19 pandemic), or similar wide-spread public health concerns and other natural or man-made disasters.

Future Outlook

The company is focused on re-establishing episodic customers impacted by the cyber incident and continues to evaluate possible candidates for joint ventures or acquisitions to expand its role as a provider of products and services to the health care industry.

Management Comments

• The company believes it is the world's largest provider of health care products and services primarily to office-based dental and medical practitioners.
• The company has a strong brand identity due to its more than 91 years of experience distributing health care products.
• The company's approach to acquisitions and joint ventures has been to expand its role as a provider of products and services to the health care industry.

Industry Context

The health care industry is increasingly focused on cost containment, which benefits distributors capable of providing a broad array of products and services at low prices. The industry is also experiencing consolidation, with health care practitioners increasingly seeking to partner with larger entities. The company believes it is positioned to capitalize on this trend.

Comparison to Industry Standards

• Henry Schein's performance in the healthcare distribution sector is comparable to other major distributors like McKesson and Cardinal Health, which also face challenges related to supply chain and pricing pressures.
• The growth in Henry Schein's technology and value-added services segment is in line with the broader trend of healthcare providers adopting digital solutions, similar to companies like Veeva Systems and Cerner.
• The impact of the cyber incident on Henry Schein's sales is a reminder of the increasing cybersecurity risks faced by healthcare companies, which is a concern for the entire industry.
• The company's debt levels are within the range of other large healthcare distributors, but the company's leverage ratios will need to be monitored closely.

Management Changes

Legal Proceedings

• Henry Schein is a defendant in multiple opioid-related lawsuits.
• The company received a Grand Jury Subpoena from the United States Attorneys Office for the Western District of Virginia related to a former subsidiary.
• The company is facing two putative class action lawsuits related to the October 2023 cyber incident.
• Henry Schein and its affiliate, North American Rescue, LLC (NAR), have been named as defendants in a qui tam lawsuit brought under the federal False Claims Act (FCA).

Related Party Transactions

• The company has a royalty agreement with Internet Brands, where it pays approximately $31 million annually for the use of their intellectual property.
• The company recorded net sales of $12 million and purchased $3 million from entities accounted for under the equity accounting method.
• Certain facilities are leased from employees and minority shareholders, with current and non-current liabilities of $5 million and $22 million, respectively.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net income and the ongoing legal proceedings.
• Employees may be affected by the restructuring plan and any potential changes in operations.
• Customers may have experienced disruptions due to the cyber incident, particularly episodic customers.
• Suppliers may be impacted by changes in the company's purchasing patterns.
• Creditors may be concerned about the company's debt levels and ongoing legal proceedings.

Next Steps

• The company plans to continue its focus on re-establishing episodic customers impacted by the cyber incident.
• The company will continue to evaluate possible candidates for joint ventures or acquisitions.
• The company will continue to monitor and manage the impact of the cyber incident and related expenses.
• The company will continue to monitor and manage the impact of the restructuring plan.

Key Dates

Keywords

healthcare distribution, technology services, cyber incident, financial results, acquisitions, medical supplies, dental supplies, restructuring, legal proceedings, stock repurchase